Clinical Research

The future of healthcare, in your hands.

In close partnership with Javara Research, we offer clinical trials for a range of health issues and conditions, including COVID-19. Join us in these important studies. With your help, we will find solutions to our most pressing medical challenges, and ensure that healthcare is working effectively and equitably for all.

We are currently enrolling patients for the following:

Hereditary Hemochromatosis Clinical Trial
Patients are needed to volunteer in a clinical trial for hemochromatosis. You may be eligible to participate if you are between 18 and 80 years of age and have been previously diagnosed with hemochromatosis. The study will require up to eight clinic visits and you will be compensated for your time.

Eosinophilic Esophagitis (EoE) Clinical Trial
If you have been diagnosed with, or think you may have EoE, you may be eligible for this study.  If you experience symptoms like difficulty swallowing, painful swallowing or the feeling that food is stuck after swallowing, you may have EoE. This study will test whether AK002 can reduce eosinophils in the blood and the tissue of the esophagus and help improve symptoms. Eligibility criteria is as follows: females and males, age 12 to 80 years old who have a confirmed diagnosis of EoE AND/OR have difficulty swallowing or discomfort when swallowing. Qualified participants will receive drugs, lab tests and medical care related to the study at no cost. Participants will be compensated for their time.

Atrial Fibrillation (AFib) Clinical Trial
We are looking for patients 70 years of age and older with Medicare insurance to wear a heart monitor device for up to two weeks. You must not be on a blood thinner and must not have a diagnosis of atrial fibrillation or flutter. You will be compensated for your time. The study will require one clinic visit.

 

Our other current enrolling trials include the following:
  • COPD
  • Colon Cancer Screening
  • Crohn’s Disease
  • Eosinophilic Gastritis and/or Eosinophilic Duodenitis
  • Focal segmental glomerulosclerosis (FSGS)
  • Gastroparesis
  • Heart Disease
  • Irritable Bowel Syndrome
  • Type II Diabetes
  • Ulcerative Colitis

To participate in one of these upcoming trials, please call 704-586-9386 or [email protected].

To stay updated on the latest news about clinical trials, sign up for Tryon Medical Partners’ email newsletter.